277 related articles for article (PubMed ID: 21938727)
1. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
4. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
Wu Q; Zhou X; Huang D; Ji Y; Kang F
Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
[TBL] [Abstract][Full Text] [Related]
5. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793
[TBL] [Abstract][Full Text] [Related]
6. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.
Kennedy OD; Herman BC; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
Bone; 2012 May; 50(5):1115-22. PubMed ID: 22342796
[TBL] [Abstract][Full Text] [Related]
7. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.
Giuliani N; Ferretti M; Bolzoni M; Storti P; Lazzaretti M; Dalla Palma B; Bonomini S; Martella E; Agnelli L; Neri A; Ceccarelli F; Palumbo C
Leukemia; 2012 Jun; 26(6):1391-401. PubMed ID: 22289923
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α induces hypoxic apoptosis of MLO-Y4 osteocytes via JNK/caspase-3 pathway and the apoptotic-osteocyte-mediated osteoclastogenesis in vitro.
Song X; Tang Y; Zhu J; Tian Y; Song Z; Hu X; Hong C; Cai Y; Kang F
Tissue Cell; 2020 Dec; 67():101402. PubMed ID: 32835935
[TBL] [Abstract][Full Text] [Related]
9. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
[TBL] [Abstract][Full Text] [Related]
13. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
14. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts.
Bakker AD; Kulkarni RN; Klein-Nulend J; Lems WF
J Dent Res; 2014 Apr; 93(4):394-9. PubMed ID: 24492932
[TBL] [Abstract][Full Text] [Related]
15. Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression.
Cheung WY; Simmons CA; You L
Bone; 2012 Jan; 50(1):104-10. PubMed ID: 21986000
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.
King TJ; Georgiou KR; Cool JC; Scherer MA; Ang ES; Foster BK; Xu J; Xian CJ
Am J Pathol; 2012 Jul; 181(1):121-9. PubMed ID: 22642908
[TBL] [Abstract][Full Text] [Related]
17. Monosodium urate crystals reduce osteocyte viability and indirectly promote a shift in osteocyte function towards a proinflammatory and proresorptive state.
Chhana A; Pool B; Callon KE; Tay ML; Musson D; Naot D; McCarthy G; McGlashan S; Cornish J; Dalbeth N
Arthritis Res Ther; 2018 Sep; 20(1):208. PubMed ID: 30201038
[TBL] [Abstract][Full Text] [Related]
18. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats.
Raghu Nadhanan R; Skinner J; Chung R; Su YW; Howe PR; Xian CJ
PLoS One; 2013; 8(8):e71592. PubMed ID: 23951199
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.
Fan CM; Foster BK; Hui SK; Xian CJ
PLoS One; 2012; 7(10):e46915. PubMed ID: 23071661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
